Changes in Beneficial Ownership · 4
Caring Brands, Inc.
CABRNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-09-28
- Issuer
- Caring Brands, Inc.
- Issuer CIK
- 0002020737
- Trading symbol
- CABR
Reporting owner 1
- Name
- Alila Hector W
- Reporting owner CIK
- 0001312210
- Relationship
- Director
- Address
- C/O CARING BRANDS, INC. 130 S INDIAN, RIVER DRIVE, SUITE 202 PBM# 1232, FORT PIERCE, FL, 34950
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | 1.24 | 2026-09-28[F1] | A · Form 4 | 50,000 | A | 0 | [F2] | 2031-09-28 | Common Stock | 50,000 | 75,000[F3] | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.↩ 1
- F2
- The options vested immediately on September 28, 2026.↩ 1
- F3
- Includes the options previously issued to the Reporting Person.↩ 1
Signature 1
- Signed
- /s/ Hector W Alila
- Date
- 2026-09-29
Company context
We are a wellness consumer products company. We offer several over-the-counter (OTC) and cosmetic consumer products. Our product pipeline includes a diverse range of products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women’s sexual wellness products, catering to diverse health and wellness needs. Our method of operation ensures that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability.